Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 268081 - 268100 out of 566329 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Germany (D) | (S01LA04) ranibizumab | LUCENTIS 10 mg/ml Injek.-Lsg.1,65 mg Fertigspr. | N1, 1 Stück, status: Rx, sales: im Vertrieb, import: ja, Org. PZN: 10108939, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Wet Macular Degeneration; Macular Edema; Diabetes Complications; Myopia, Degenerative; Choroidal Neovascularization | Orifarm |
| Germany (D) | (S01LA04) ranibizumab | LUCENTIS 10 mg/ml Injek.-Lsg.1,65 mg Fertigspr. | N1, 1 Stück, status: Rx, sales: im Vertrieb, import: ja, Org. PZN: 10108939, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Wet Macular Degeneration; Macular Edema; Diabetes Complications; Myopia, Degenerative; Choroidal Neovascularization | EurimPharm |
| Germany (D) | (S01LA04) ranibizumab | LUCENTIS 10 mg/ml Injek.-Lsg.1,65 mg Fertigspr. | N1, 1 Stück, status: Rx, sales: im Vertrieb, import: ja, Org. PZN: 10108939, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Wet Macular Degeneration; Macular Edema; Diabetes Complications; Myopia, Degenerative; Choroidal Neovascularization | Kohlpharma |
| Germany (D) | (S01LA04) ranibizumab | LUCENTIS 10 mg/ml Injek.-Lsg.1,65 mg Fertigspr. | N1, 1 Stück, status: Rx, sales: im Vertrieb, import: ja, Org. PZN: 10108939, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Wet Macular Degeneration; Macular Edema; Diabetes Complications; Myopia, Degenerative; Choroidal Neovascularization | 2Care4 |
| Germany (D) | (S01LA04) ranibizumab | LUCENTIS 10 mg/ml Injekt.-Lsg.2,3mg Durchstechfl. | N1, 1 Stück, status: Rx, sales: im Vertrieb, import: ja, Org. PZN: 00067760, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Wet Macular Degeneration; Macular Edema; Diabetes Complications; Myopia, Degenerative; Choroidal Neovascularization | Kohlpharma |
| Germany (D) | (S01LA04) ranibizumab | LUCENTIS 10 mg/ml Injekt.-Lsg.2,3mg Durchstechfl. | N1, 1 Stück, status: Rx, sales: außer Vertrieb, import: ja, Org. PZN: 00067760, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Wet Macular Degeneration; Macular Edema; Diabetes Complications; Myopia, Degenerative; Choroidal Neovascularization | NMG |
| Germany (D) | (S01LA04) ranibizumab | LUCENTIS 10 mg/ml Injekt.-Lsg.2,3mg Durchstechfl. | N1, 1 Stück, status: Rx, sales: im Vertrieb, import: nein, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Wet Macular Degeneration; Macular Edema; Diabetes Complications; Myopia, Degenerative; Choroidal Neovascularization | NovartisPharma |
| Germany (D) | (S01LA04) ranibizumab | LUCENTIS 10 mg/ml Injekt.-Lsg.2,3mg Durchstechfl. | N1, 1 Stück, status: Rx, sales: im Vertrieb, import: ja, Org. PZN: 00067760, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Wet Macular Degeneration; Macular Edema; Diabetes Complications; Myopia, Degenerative; Choroidal Neovascularization | HAEMATO |
| Germany (D) | (S01LA04) ranibizumab | LUCENTIS 10 mg/ml Injekt.-Lsg.2,3mg Durchstechfl. | N1, 1 Stück, status: Rx, sales: außer Vertrieb, import: ja, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Wet Macular Degeneration; Macular Edema; Diabetes Complications; Myopia, Degenerative; Choroidal Neovascularization | Lunapharm |
| Germany (D) | (S01LA04) ranibizumab | LUCENTIS 10 mg/ml Injekt.-Lsg.2,3mg Durchstechfl. | N1, 1 Stück, status: Rx, sales: im Vertrieb, import: ja, Org. PZN: 00067760, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Wet Macular Degeneration; Macular Edema; Diabetes Complications; Myopia, Degenerative; Choroidal Neovascularization | Hvdmedical |
| Germany (D) | (S01LA04) ranibizumab | LUCENTIS 10 mg/ml Injekt.-Lsg.2,3mg Durchstechfl. | N1, 1 Stück, status: Rx, sales: im Vertrieb, import: ja, Org. PZN: 00067760, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Wet Macular Degeneration; Macular Edema; Diabetes Complications; Myopia, Degenerative; Choroidal Neovascularization | Orifarm |
| Germany (D) | (S01LA04) ranibizumab | LUCENTIS 10 mg/ml Injekt.-Lsg.2,3mg Durchstechfl. | N1, 1 Stück, status: Rx, sales: im Vertrieb, import: ja, Org. PZN: 00067760, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Wet Macular Degeneration; Macular Edema; Diabetes Complications; Myopia, Degenerative; Choroidal Neovascularization | Medicopharm |
| Germany (D) | (S01LA04) ranibizumab | RANIVISIO 10 mg/ml Injekt.-Lsg.2,3mg Durchstechfl. | N1, 1 Stück, status: Rx, sales: im Vertrieb, import: nein, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Wet Macular Degeneration; Macular Edema; Diabetic Retinopathy; Diabetes Complications | Ratiopharm |
| Germany (D) | (S01LA04) ranibizumab | RANIVISIO 10 mg/ml Injekt.-Lsg.2,3mg Durchstechfl. | N1, 1 Stück, status: Rx, sales: im Vertrieb, import: ja, Org. PZN: 17946164, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Wet Macular Degeneration; Macular Edema; Diabetic Retinopathy; Diabetes Complications | Orifarm |
| Germany (D) | (S01LA04) ranibizumab | RANIVISIO 10 mg/ml Injekt.-Lsg.2,3mg Durchstechfl. | N1, 1 Stück, status: Rx, sales: im Vertrieb, import: ja, Org. PZN: 17946164, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Wet Macular Degeneration; Macular Edema; Diabetic Retinopathy; Diabetes Complications | SynCo |
| Germany (D) | (S01LA04) ranibizumab | XIMLUCI 10 mg/ml Injekt.-Lsg. 2,3 mg Durchstechfl. | N1, 1 Stück, status: Rx, sales: im Vertrieb, import: nein, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Wet Macular Degeneration; Macular Edema; Diabetic Retinopathy; Diabetes Complications | STADAPHARM |
| Germany (D) | (S01LA05) aflibercept | EYLEA 40 mg/ml Injektionslösung Durchstechflasche | N1, 1 Stück, status: Rx, sales: im Vertrieb, import: ja, Org. PZN: 09299319, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Wet Macular Degeneration; Macular Edema; Diabetes Complications | AxicorpPharma |
| Germany (D) | (S01LA05) aflibercept | EYLEA 40 mg/ml Injektionslösung Durchstechflasche | N1, 1 Stück, status: Rx, sales: im Vertrieb, import: ja, Org. PZN: 09299319, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Wet Macular Degeneration; Macular Edema; Diabetes Complications | ACAMüller |
| Germany (D) | (S01LA05) aflibercept | EYLEA 40 mg/ml Injektionslösung Durchstechflasche | N1, 1 Stück, status: Rx, sales: außer Vertrieb, import: ja, Org. PZN: 09299319, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Wet Macular Degeneration; Macular Edema; Diabetes Complications | CareCept |
| Germany (D) | (S01LA05) aflibercept | EYLEA 40 mg/ml Injektionslösung Durchstechflasche | N1, 1 Stück, status: Rx, sales: im Vertrieb, import: ja, Org. PZN: 09299319, Standardpackung | Retail price with vat |
$0-0 |
$0-0 |
Wet Macular Degeneration; Macular Edema; Diabetes Complications | Orifarm |
Pages
